Discovery of the First Vitamin K Analogue as a Potential Treatment of Pharmacoresistant Seizures.

Discovery of the First Vitamin K Analogue as a Potential Treatment of Pharmacoresistant Seizures.
复制标题

DOI:
10.1021/acs.jmedchem.0c00168
复制
发表时间:
2020-06-11
影响因子:
7.3
通讯作者:
Chou CJ
Chou CJ
中科院分区:
医学1区
文献类型:
--
作者:
Li X;Himes RA;Prosser LC;Christie CF;Watt E;Edwards SF;Metcalf CS;West PJ;Wilcox KS;Chan SSL;Chou CJ

文献摘要

参考文献

相似文献

尽管市场上有25种以上的抗癫痫药物,但大约30%的癫痫患者仍然遭受癫痫发作的折磨。因此,癫痫治疗市场非常需要一种能够帮助耐药患者的突破性药物。在我们之前的研究中,我们发现了一种维生素K类似物2h,它在斑马鱼和小鼠癫痫模型中显示出适度的抗癫痫活性。然而,由于其药代动力学特征,该化合物存在局限性。在本研究中,我们通过修饰2h的结构,开发了一系列新的维生素K类似物。其中,化合物3d在啮齿动物耐药癫痫模型中显示出充分的保护作用,具有有限的旋转动物运动毒性和良好的PK特性。此外,3d的脑/血浆浓度比表明其对脑具有良好的通透性。结果表明3d可以作为一种潜在的抗癫痫药物在临床上进一步发展。
Despite the availability of more than 25 anti-seizure drugs on the market, approximately 30% of patients with epilepsy still suffer from seizures. Thus, the epilepsy therapy market has a great need for a breakthrough drug that will aid pharmacoresistant patients. In our previous study, we discovered a vitamin K analog, 2h, which displayed modest anti-seizure activity in zebrafish and mouse seizure models. However, there were limitations for this compound due to its pharmacokinetic profile. In this study, we developed a new series of vitamin K analogs by modifying the structure of 2h. Among these, compound 3d shows full protection in a rodent pharmacoresistant seizure model with limited rotarod motor toxicity and favorable PK properties. Furthermore, the brain/plasma concentration ratio of 3d indicates its excellent permeability to the brain. The resulting data shows 3d can be further developed as a potential anti-seizure drug in the clinic.
DOI: 10.1016/j.neuroscience.2013.11.040
发表时间: 2014-02-14
期刊: NEUROSCIENCE
影响因子: 3.3
作者:
Rahn, J. J.;Bestman, J. E.;Josey, B. J.;Inks, E. S.;Stackley, K. D.;Rogers, C. E.;Chou, C. J.;Chan, S. S. L.
通讯作者: Chan, S. S. L.
DOI: 10.1016/s0920-1211(01)00302-3
发表时间: 2001-12-01
期刊: EPILEPSY RESEARCH
影响因子: 2.2
作者:
Barton, ME;Klein, BD;White, HS
通讯作者: White, HS
DOI: 10.1111/j.1528-1167.2005.22705.x
发表时间: 2005-09-01
期刊: EPILEPSIA
影响因子: 5.6
作者:
Lyczkowski, DA;Pfeifer, HH;Thiele, EA
通讯作者: Thiele, EA
DOI: 10.1007/s11064-017-2275-z
发表时间: 2017-07-01
影响因子: 4.4
作者:
Kehne, John H.;Klein, Brian D.;Sharma, Shalini
通讯作者: Sharma, Shalini
DOI: 10.1111/epi.13764
发表时间: 2017-06
期刊: Epilepsia
影响因子: 5.6
作者:
Metcalf CS;West PJ;Thomson KE;Edwards SF;Smith MD;White HS;Wilcox KS
通讯作者: Wilcox KS